NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines
Greater Glasgow and Clyde Medicines
For all prescribers and health professionals both in primary care and the acute sector.
Please note, Medicines Update blogs are correct at the time of publication.
All editions of PostScript (the previous name for Medicines Update) from 2011 onwards have been added to this site. Click here for an index to all previous editions. If you would like a copy of a previous edition, please contact medicines.update@ggc.scot.nhs.uk
Click here for further information on Medicines Update and recent survey results.
If you would like to contribute to Medicines Update, click here for a guide to blog writing.
Posted: September 05, 2014.
Category - Medicines Update
NHSGGC contributions to Glasgow 2014 Medical Services Although the Commonwealth Games lasted only 11 days, planning has taken many years. One of the things spectators wouldn’t be aware of was the effort that had gone into planning...
Posted: August 06, 2014.
Category - Medicines Update
Formerly known as PostScript these bulletins have been re-launched as Medicines Update.
The bulletins provide information on:
There are currently 5 bulletins produced each with slightly differing remit:
Posted: July 07, 2014.
Category - Medicines Update
Posted: July 07, 2014.
Category - Medicines Update
Posted: July 07, 2014.
Category - Medicines Update
Posted: July 07, 2014.
Category - Medicines Update
Posted: July 07, 2014.
Category - Medicines Update
Posted: July 07, 2014.
Category - Medicines Update
This edition can be accessed in PDF format here and contains articles on: Dual Antiplatelet Therapy Safety Update: Do...
Posted: May 05, 2014.
Category - Medicines Update
This edition can be accessed in PDF format here and contains articles on: Novel oral anticoagulant update New oral products for multiple sclerosis Tramadol to become controlled drug ...
Posted: May 05, 2014.
Category - Medicines Update
Tagged with - Anticoagulants
Inclusion of the NOACs (dabigatran, rivaroxaban, apixaban) on the NHSGGC Formulary is established for existing patients with non-valvular atrial fibrillation (AF) who are intolerant of, or poor...